https://en.sputniknews.africa/20241008/marburg-fever-vaccine-shows-effectiveness-in-preclinical-trials-russian-consumer-watchdog-says-1068599802.html
Marburg Fever Vaccine Shows Effectiveness in Preclinical Trials, Russian Consumer Watchdog Says
Marburg Fever Vaccine Shows Effectiveness in Preclinical Trials, Russian Consumer Watchdog Says
Sputnik Africa
MOSCOW (Sputnik) - Marburg fever is notorious for its high mortality rate, reaching up to 88%. Symptoms often involve intense headache, vomiting, muscle pain... 08.10.2024, Sputnik Africa
2024-10-08T14:52+0200
2024-10-08T14:52+0200
2024-10-08T16:00+0200
sub-saharan africa
russia
rwanda
east africa
vaccine
marburg virus
human
humanitarian aid
russia-africa cooperation
cooperation
https://cdn1.img.sputniknews.africa/img/07e8/08/0f/1067873190_0:159:2802:1735_1920x0_80_0_0_3edc2603658c67176dc0dfc1c135ec21.jpg
The Russian Consumer Watchdog, Rospotrebnadzor, announced on Tuesday that the State Research Center of Virology and Biotechnology Vector has created a vaccine for Marburg fever, which has successfully completed preclinical trials, demonstrating its effectiveness.The vaccine is in a high degree of readiness for clinical trials. The vaccine series is currently being developed, and a package of documents for obtaining the relevant authorization is being prepared, the watchdog said.Rwanda's Health Minister, Sabin Nsanzimana, announced last Sunday that the country has started vaccinating people against the Marburg virus to combat an outbreak that has resulted in 12 deaths. The vaccination effort will prioritize those "most at risk," including healthcare workers in treatment centers, hospitals, ICUs, and emergency departments, as well as individuals who have been in close contact with confirmed cases.
https://en.sputniknews.africa/20241007/africas-first-vaccination-campaign-against-marburg-starts-in-rwanda-1068580334.html
russia
rwanda
east africa
Sputnik Africa
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2024
Sputnik Africa
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik Africa
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik Africa
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
russia, rwanda, east africa, vaccine, marburg virus, human, humanitarian aid , russia-africa cooperation, cooperation, health, healthcare
russia, rwanda, east africa, vaccine, marburg virus, human, humanitarian aid , russia-africa cooperation, cooperation, health, healthcare
Marburg Fever Vaccine Shows Effectiveness in Preclinical Trials, Russian Consumer Watchdog Says
14:52 08.10.2024 (Updated: 16:00 08.10.2024) MOSCOW (Sputnik) - Marburg fever is notorious for its high mortality rate, reaching up to 88%. Symptoms often involve intense headache, vomiting, muscle pain, and abdominal discomfort. The virus is initially transmitted from fruit bats to humans and then spreads via direct contact with the bodily fluids of those infected.
The Russian Consumer Watchdog,
Rospotrebnadzor, announced on Tuesday that the State Research Center of Virology and Biotechnology Vector has created a vaccine for Marburg fever, which has successfully completed preclinical trials, demonstrating its effectiveness.
"Employees of Rospotrebnadzor's Vector State Research Center have developed a vaccine to prevent Marburg fever. The development has already passed preclinical tests, having shown its safety and effectiveness," the statement said.
The vaccine is in a high degree of readiness for clinical trials. The vaccine series is currently being developed, and a package of documents for obtaining the relevant authorization is being prepared, the watchdog said.
Rwanda's Health Minister, Sabin Nsanzimana, announced last Sunday that the country has started vaccinating people against the Marburg virus to combat an outbreak that has resulted in 12 deaths. The vaccination effort will prioritize those "most at risk," including healthcare workers in treatment centers, hospitals, ICUs, and emergency departments, as well as individuals who have been in close contact with confirmed cases.
